Investment support for early-stage translation


Feedback essential for commercialising early-stage projects and technologies is being offered by an expert and investor group at AusMedtech’s Early Stage Investment Forum. Early-stage projects are invited to apply for the AusMedtech 2021 Early Stage Investment Forum, with submissions due 9 April 2021.

The Forum offers six-minute virtual quick-pitches to an expert investor panel that will include international big pharma representatives, corporate VCs and early-stage investors. Each presentation will be followed by direct feedback that will be valuable during translation and commercialisation.

In an exciting new development, the Forum is being held for the first time at AusMedtech 2021, Australia’s premier medtech event, and will be supported by Medtronic. The Forum will take place on Friday 21 May.

Early-stage technologies and projects are being sought from across Australia from research institutes, universities, hospitals and pre-series A companies in the areas of medical devices and diagnostics, digital health and enabling technologies.

AusBiotech is dedicated to the development, growth and prosperity of the Australian biotechnology industry and facilitates opportunities for investment discussions, collaborations and partnerships. To encourage, recognise and reward early-stage technology and projects, an award for Best Translational Research will also be up for grabs.

AusMedtech 2021: Reimagine and reconnect offers a week of inclusive half-day virtual sessions that represent Australia’s medtech industry. Reconnect with a network of resilient and innovative leaders, and reimagine the future of medtech beyond our borders.

Run by industry, for industry, AusMedtech week features a mix of cutting edge leading keynotes, expert panel discussions, and Q&A, bringing together key stakeholders of the Australian and international medical devices and diagnostics sector to help prepare the industry sector for its changing landscape.

AusMedtech 2021 is supported by the Victorian Government as the Host State Partner.

Submit your application for the AusMedtech 2021 Early Stage Investment Forum by 9 April.

Companies outside of the early-stage criteria are encouraged to contact Hayley Laing, AusBiotech’s Manager, Global Investment Programme, to explore other opportunities to connect with capital.